Oracle's founder just killed a $7.5bn sale. That's a signal.

Transcript

Tom Larry Ellison just cancelled a seven and a half billion dollar Oracle share sale, one day after filing. That's a founder saying the stock is too cheap at his own price.

Marie Good morning — it's the Weekend Edition, September 13th, 2026. I'm Marie, and with me are Tom and Gerald.

Tom Hey, Marie — your sell Dollar-yen call from yesterday is looking smart already with the Bank of Japan hiking. Nice one.

Marie Ha — thanks, Tom. Sometimes the macro board lines up. Alright, let's get into today's signals.

Marie We've got ten groups today, starting with Oracle, pharma rotation, AI proxies, India I P O, Japan steel, defence, data centres, Vietnam, Recordati, and Thailand risk.

Tom So three major outlets all carried the Oracle reversal — FT, The Information, Wall Street Journal. That's a narrative shift, buddy.

Gerald Yeah, but Oracle is still fifty-four percent below its high and down twenty-three percent year to date. One pulled sale doesn't fix the cloud competition.

Marie But it removes a supply overhang before any fundamental turn, and at thirteen point seven times forward earnings, that's the cheapest confidence signal you can get.

Tom Exactly — that's the whole story.

Marie The Wall Street Journal has a piece saying heart disease, the world's biggest killer, is now pharma's worst business because pricing pressure and generics killed the blockbuster model.

Tom No but think about it — Lilly and Novo Nordisk are capturing those same patients through weight-loss drugs without needing a cardiovascular label. That's genius.

Gerald Right, so you want to buy Lilly at fourteen percent below its high, but Novo is thirty-three percent below. The rotation is real but the easy money might be in the laggard.

Marie And that's why the sell call on Pfizer is interesting — it's only five percent below its high after a ten percent run, priced for perfection in the wrong franchise.

Tom Pfizer's the value trap.

Gerald Totally.

Marie One hundred percent.

Tom Sam Altman said OpenAI won't I P O this year. Safety concerns, his words. That keeps the equity story inside Microsoft.

Gerald Sure, but Microsoft is only eleven percent below its high, Alphabet seventeen, Amazon eleven. None of them are screaming bargains.

Marie The real angle is funding cost. Private OpenAI can't tap public markets, so listed AI labs keep a cheap capital advantage. That's structural.

Tom Exactly, and that's why I like Alphabet here at twenty-three times forward earnings and seventeen percent off highs.

Marie The Reserve Bank of India rejected Tata Sons' application to avoid an I P O. That could force the biggest listing in India's history.

Gerald Yeah but no one's pricing the knock-on effect on Tata Consultancy Services — it's thirty-four percent below its high and a listing could reprice the holding company discount.

Tom Buddy, a record India I P O into a beaten-down tape? That's a re-rating catalyst for the whole India equities ETF, and it's thirteen percent off its high.

Tom Nippon Steel just spent two billion dollars on its largest single asset ever — a hot rolling line targeting automotive share. Nikkei Asia calls it a contrarian bet.

Gerald Contrarian? It's a zero-sum game in a shrinking market. They're explicitly taking volume from JFE and smaller producers.

Marie Right, and that's why the sell call on JFE is clean — if Nippon gains, JFE loses. And the steel ETF watch adds global glut pressure.

Marie Two defence stories today — a German startup wants carmakers to build unmanned vehicles, and Tokyo plans subsidies for emergency drone and ammunition capacity.

Tom This is the rearmament trade broadening beyond the primes. Rheinmetall is fifty-one percent below its high, that's crazy cheap for this theme.

Gerald Careful, mate. That fifty-one percent discount tells you the market doesn't believe the backlog converts. Volkswagen at point two three times book is a value trap, not a re-rating.

Marie But Mitsubishi Heavy is the named drone partner, so subsidised capex flows to them first. That's a structural winner.

Gerald An FT exclusive says campaigners want Equinix's South African data centre approval overturned over power and water. That's resource constraints as a real gate.

Tom Yeah but data centre demand is still booming, Equinix is only eight percent off its high, and it's up thirty-six percent this year.

Marie Wait — that's exactly my point, Tom. It's pricing perfect permitting at fifty-five times forward earnings. One water-stressed precedent and the most expensive names get rerated.

Marie Vietnam's richest man is handing control of his empire to his sons. That's a succession question for Vingroup, Vinhomes, and VinFast, which is down thirty-nine percent from its high.

Tom VinFast is a cash-burning story reliant on the founder's personal backing. If the sons change strategy, that's a risk.

Gerald Ah, family governance — always the best way to boost a stock's risk premium.

Tom Ha — fair enough.

Marie He's not wrong.

Gerald Investors are accusing CVC of a lowball ten point seven billion euro offer for Recordati. Public fights like that often force a sweeter bid.

Marie Exactly, and Recordati is only five percent below its fifty-two-week high. A sweeter offer isn't priced in yet.

Tom But CVC's reputation takes a hit too, and their stock is sixteen percent below its high. Sometimes the fight damages the buyer.

Tom Nidec is exiting Cambodia because of the Thailand border conflict. That's a supply-chain casualty markets are mostly ignoring.

Gerald And Thailand's ETF is up twenty-four percent year to date and within one percent of its high. No discount for that risk at all.

Marie This is the kind of tail risk that hits regional flows later. Selling Thailand here is a hedge against complacency.

Tom Complacency is the trade.

Gerald Yep.

Marie Nailed it.

Marie The WSJ piece on heart disease is our most original take today — the world's biggest killer becoming pharma's worst business. It flips the logic: large market doesn't mean large opportunity.

Tom And that's why Lilly and Novo win — they capture the cardiovascular patient pool without needing a cardiovascular label.

Gerald But the counter-argument is that Oracle is still down twenty-three percent year to date for a reason. One cancelled sale doesn't fix cloud competition. The defence thesis has been around for years, and Rheinmetall is still fifty-one percent below its high.

Marie Right — either the easy money is gone or the market doesn't believe the backlog converts. If carmakers treat defence work as marginal, Volkswagen at point two three times book becomes a value trap.

Tom But the thing that stands out is the silence on Tata Sons. Nobody is pricing the holding company discount across the Tata complex, even though Tata Consultancy is thirty-four percent below its high.

Gerald That's the arb — a forced listing is the cleanest vehicle to reprice that discount. The silence is the trade.

Marie And the cleanest cross-market expression is the spread between resource-rich data centre owners and resource-constrained build-outs. Equinix at fifty-five times forward is pricing perfect permitting; South Africa says that's not guaranteed.

Tom So you fade the most-priced-in leg of the AI infrastructure trade, not the whole sector.

Marie Exactly. And as always, none of this is investment advice.

Gerald We're back to the Weekend Edition theme: founders and regulators moving faster than markets. Ellison cancels a sale, the RBI forces an I P O, Tokyo subsidises drones.

Tom And it's all about capital being pulled or redirected, not left to markets.

Marie If you're just finding us, hit follow on Spotify — or check investmentflash.com for the full digest with charts and sources.

Tom We're back Monday's London Edition at seven-thirty a.m. London time — have a great rest of the weekend.

Gerald And Tom, try not to buy anything over the weekend.

Tom No promises, buddy.